As compared traditional biomarkers, PTX3 has been found to be a sensitive non-invasive biomarker of clinical arthritis activity in RA (Sharma et al., 2018), indicating that ER, CRP and PTX3 may play a significant role in improving arthritis. Here, PTX3 is linked to arthritic joint disease.